Biogen

Biogen Inc. is a leading global biotechnology company focused on discovering, developing, and delivering innovative therapies for neurological and neurodegenerative diseases. Headquartered in Cambridge, Massachusetts, Biogen is renowned for its pioneering work in multiple sclerosis, spinal muscular atrophy, Alzheimer’s disease, and other serious conditions. The company leverages cutting-edge science and a robust research pipeline to address unmet medical needs, aiming to improve the lives of patients worldwide.